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Abstract
Background: Alkaptonuria (AKU) is a disorder of tyrosine/protein metabo-
lism leading to accumulation of homogentisic acid. Clinical management his-
torically recommended reducing dietary protein intake, especially in
childhood, which has since been discredited in the literature. For the first time,
analysis of baseline cross-sectional nutritional surveillance data from a large
cohort of AKU patients is presented, which has clinical implications in all
aspects of treatment planning.
Method: Seventy-four patients (mean 55 years) admitted to the National
Alkaptonuria Centre (NAC), underwent a global nutritional assessment, which
included objective anthropometry, bioimpedance measures, habitual nutri-
tional intake using a 7-day food diary and key nutritional biomarkers, includ-
ing 24 hours urinary nitrogen, serum albumin, total protein and total
25-hydroxy vitamin D. All data was compared with cohort norms or rec-
ommended nutrient intakes for health (RNI). The potential beneficial impact
of protein and anti-inflammatory nutrients such as vitamin C, selenium, and
zinc were statistically interrogated against the AKU severity score index
(AKUSSI)—a validated measure of disease progression stratified by age.
Results: Fifty percent of AKU patients reported some level of protein restric-
tion at some point in their lives. In comparison with national data sets, AKU
patients present with significantly lower than predicted mid-upper arm cir-
cumference, grip strength, BMI, total energy and protein intake, and higher
than predicted percentage body fat. They therefore meet the ESPEN criteria as
“clinically undernourished.” Severity fluctuates over the life course. No statisti-
cal association is identified between protein intake, expressed as %RNI or g/kg,
or anti-inflammatory nutrients, including vitamin C as a high dose supplement
on the severity of the disease, when correlated against the validated AKUSSI
score.
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Conclusion: AKU patients are at risk of protein depletion associated with a
“perfect storm” of risk factors: historical, poorly evidenced recommendations
to reduce total protein intake; limited mobility as the condition progresses,
compromising muscle integrity; frequent hospital admissions for major surgery
associated with multiple joint replacements, creating pinch points of high met-
abolic demand and the potential impact of the disease itself. As this is the first
time this risk has been identified, the authors consider the dietetic implications
of nitisinone treatment, which requires dietary protein control to manage the
acquired tyrosinaemia. The lack of statistically significant evidence to support
dietary manipulation of any kind to impede disease progression in AKU is
demonstrated.
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1 | INTRODUCTION
Alkaptonuria (AKU, OMIM#203500), results from muta-
tions in the homogentisate 1,2 dioxygenase gene (HGD,
EC 1.13.11.5),1 increasing circulating homogentisic acid
(HGA) and urinary HGA, an intermediary metabolite in
the catabolism of the amino acids phenylalanine and
tyrosine. HGA oxidizes to benzoquinoneacetic acid
(BQA) that deposits ochronotic pigment in soft tissues,
cartilage and connective tissue, most typically causing
severe arthritis of weight bearing joints and spine.2
With no proven disease modifying therapy for AKU,
treatment approaches were historically supportive (phys-
iotherapy and analgesia) and palliative (spinal surgery
and joint replacement). There is no definitive dietary
treatment recommended for AKU; however, limiting pro-
tein intake in childhood3 and high dose ascorbic acid4,5
are two cited dietary strategies.
This report presents an overview of the nutritional
status of patients with AKU at the initial baseline visit to
the UK National AKU Centre (NAC), which was
established in 2012. The overall nutritional status of this
cohort is presented and asks if there is an association
between habitual food intake and the severity of the con-
dition, using the validated numerical AKUSSI score.6 The
dietetic implications for supporting the NAC's treatment
protocol of providing HGA lowering therapy using off
license 2 mg nitisinone/day are then considered.
There is little published evidence to guide the use of a
lower tyrosine intake to modify AKU disease progression
or minimize the consequences of postnitisinone
tyrosinaemia. It is thus crucial to more fully understand
the role diet plays in AKU.
2 | METHODS
2.1 | Study population
Forty-seven males (64%) and 27 females (36%) with a
median age of 55 (range 17-72 years) and a confirmed
diagnosis of AKU were included in the study. These
74 patients attended the NAC from 2012 to 2018.
Patients underwent a global nutritional assessment,
which included objective anthropometry (Table 1),
habitual nutritional intake using a 7-day food diary
(Table 2) and nutritional biomarkers, including
24-hours urinary nitrogen and serum albumin, total pro-
tein, 25-hydroxy vitamin D and hemoglobin (Table 3).
The findings were compared with key national reference
sources, the National Diet and Nutrition Survey7 and
current UK recommendations for health—The Eat well
Guide (www.gov.uk;8). Statistical comparisons were
made with the age and sex specific UK Reference Nutri-
ent Intakes (RNI's) for each nutrient9,10 and body com-
position reference data used in routine clinical
practice.11
SYNOPSIS
Adults with AKU are likely to be clinically under-
nourished, exacerbated by frequent surgical inter-
ventions over their life course. Management of
nitisinone-induced tyrosinaemia, potentially exac-
erbates this. Specialist dietetic support is needed
to safeguard patients' nutritional status.
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TABLE 1 Body composition
Variable Number Median IQR Mean SD Nearest centile to the mean
1(a)
MUAC (cm) 74 29.9 27.0-32.5 30.0 3.8
Male 47 30.0 28-32.5 30.2 3.2 15
Female 27 29.0 26.0-32.5 29.6 4.7 Mid-point of 25th and 50th
Males (age)
20-29 7 32.5 25.5-34.0 30.7 4.0 15
30-39 5 31.5 28.6-32.0 30.7 2.1 15
40-49 12 31.6 29.4-33.0 31.1 2.7 15
50-59 12 29.2 28.0-31.0 29.9 3.6 15
60-69 7 29.0 26.6-32.3 28.9 3.1 10
70-79 2 29.1 25.6-32.5 29.1 4.9 15
Females (age)
20-29 0 – – – – –
30-39 5 29.0 27.0-33.4 31.7 7.2 50
40-49 3 26.0 24.6-32.4 27.7 4.2 15
50-59 5 30.0 29.0-30.5 31.4 4.6 50
60-69 10 31.1 28.0-32.5 30.1 2.9 25
70-79 1 25.0 25.0-25.0 25.0 15
Variable Number Median IQR Mean SD
1(b)
Muscle mass (kg) 49 51.4 42.4-55.9 49.2 9.0
Male 34 39.3 50.2-58.3 53.8 6.5
Female 15 53.6 36.2-42.4 39.0 4.4
Males (age)
19-64 29 54.5 51.9-58.7 54.8 6.3
≥65 4 46.9 43.4-50.5 47.0 4.4
Females (age)
19-64 10 40.2 36.2-42.8 40.1 4.2
≥65 5 36.6 35.2-39.3 36.8 4.4
Variable Number Median IQR Mean SD Normal/85%
1(c)
Grip strength (kg) 49 29.8 22.0-35.5 29.7 13.2
Male 34 33.8 26.3-39.1 33.1 13.3 40/34
Female 15 21.0 17.2-24.9 22.0 9.2 27.5/23
Males (age)
18-69 32 33.8 26.2-39.2 33.2 13.7 40/34
70-79 2 31.7 29.1-34.3 31.7 3.7 32.5/27.5
Females (age)
18-69 14 20.2 17.2-24.6 21.8 9.5 27.5/23
70-79 – n/a n/a n/a n/a 25.0/21
Variable Number Median IQR Mean SD Nearest centile to the mean
1(d)
% Body fat (50 kHz BIA) 49 25.2 22.0-30.9 26.2 9.3
Male 34 24.6 20.3-28.5 24.8 8.8 75
Female 15 28.2 24.1-35.0 29.5 9.8 50
(Continues)
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TABLE 1 (Continued)
Variable Number Median IQR Mean SD Nearest centile to the mean
Males (age)
18-24 2 6.6 5.7-6.6 6.6 1.2 5
25-34 3 23.0 21.0-51.2 31.7 16.9 >95th
35-44 8 25.3 20.2-33.7 27.0 8.7 90
45-54 11 26.0 23.1-28.5 26.2 4.6 90
55-64 6 24.8 20.3-26.6 23.8 4.9 50
65-74 4 20.6 15.1-28.9 22.0 8.8 25
Females (age)
18-24 1 25.9 25.9-25.9 25.9 – 50
25-34 2 30.9 23.0-38.8 30.9 11.2 75
35-44 3 28.2 24.1-30.9 27.7 3.4 50
45-54 2 16.7 8.6-24.7 16.7 11.4 5
55-64 2 34.5 26.3-42.6 34.5 11.5 50
65-74 4 33.3 31.3-42.5 36.9 8.9 25
Variable Number Median IQR Mean SD England mean 2014
1(e)
BMI (kg/m2) 72 26.8 23.0-29.0 26.7 5.2 24.1
Male 45 26.9 24.8-29.0 26.9 4.3 27.2
Female 27 25.7 21.3-29.0 26.3 6.6 27.2
Males (age)
18-24 4 22.4 19.2-26.5 22.8 4.5 23.8
25-34 6 25.6 24.8-28.9 25.5 3.7 26.4
35-44 10 26.8 25.5-31.1 28.1 4.8 27.7
45-54 12 27.8 25.3-30.5 28.0 4.2 28.4
55-64 8 27.0 25.9-27.9 27.2 3.0 28.9
65-74 5 29.2 20.8-30.1 26.5 5.5 27.9
Females (age)
18-24 2 20.5 19.9-21.0 20.5 0.8 24.4
25-34 3 29.9 21.0-47.7 32.9 13.6 26.2
35-44 4 23.3 22.0-26.5 24.2 3.3 27.2
45-54 2 20.5 17.4-23.6 20.5 4.4 28.1
55-64 9 28.8 25.7-30.0 27.9 5.3 28.6
65-74 6 27.2 23.6-28.1 27.3 4.2 28.4
Variable Number Median IQR Mean SD England BMI mean 2014
1(f)
BMIPTH 74 25.2 22.5-28.3 25.6 4.1 24.1
Male 47 25.5 23.5-28.1 25.5 3.33 27.2
Female 27 24.9 21.7-29.2 25.8 5.21 27.2
Males (age)
18-24 4 22.9 20.1-26.3 23.2 3.6 23.8
25-34 6 26.2 23.5-28.7 26.2 4.5 26.4
35-44 10 26.8 24.1-28.3 26.5 2.8 27.4
(Continues)
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TABLE 1 (Continued)
Variable Number Median IQR Mean SD England BMI mean 2014
45-54 13 26.4 23.5-27.5 26.0 3.7 28.4
55-64 8 24.8 23.5-25.7 24.4 2.4 28.9
65-74 6 24.4 22.4-28.5 25.0 3.0 27.9
Females (age)
18-24 2 20.7 19.2-22.1 20.7 2.1 24.4
25-34 3 29.4 22.5-40.6 30.8 9.1 26.2
35-44 4 22.9 20.6-26.7 23.6 3.9 27.2
45-54 2 24.0 21.7-26.3 24.0 3.3 28.1
55-64 9 25.2 24.1-29.2 25.9 5.5 28.6
65-74 7 27.7 24.4-29.4 26.8 3.4 28.4
TABLE 2 Nutritional intake
Variable Number Median IQR Mean SD NSDS mean
Energy (kcal) 72 1679.0 1397.5-2013.0 1730.9 455.0 1849
Male 46 1883.0 1459.0-2227.0 1856.7 454.4 1971
Female 26 1452.0 1244.0-1684.0 1508.4 368.3 1542
Males (age)
19-64 39 1907.0 1519.0-2313.0 1910.4 465.4 2107
≥65 6 1452.5 1360.0-1674.0 1531.0 242.2 1835
Females (age)
19-64 19 1466.0 1143.0-1835.0 1544.7 422.9 1595
≥65 7 1438.0 1296.0-1519.0 1409.6 114.0 1488
Fe %RNI 71 105.0 77.0-130.0 106.6 38.3 Mean %RNI
Male 45 113.0 88.0-139.0 116.6 33.4 130
Female 26 87.0 58.0-110.0 89.4 40.7 91
Folate %RNI 71 100.0 75.0-134.0 106.0 39.9 Mean %RNI
Male 45 107.0 77.0-138.0 111.8 41.5 135
Female 26 87.0 75.0-110.0 95.9 35.4 108
Ca %RNI 71 105.0 85.0-151.0 115.7 42.6 Mean %RNI
Male 45 126.0 88.0-158.0 125.7 44.0 125
Female 26 94.5 76.0-109.0 98.5 34.3 107
Fiber g(NSP) aim 18 g 72 12.5 9.0-16.0 13.7 6.2 14
Male 46 13.0 10.0-17.0 14.5 6.7 15
Female 26 11.5 8.0-15.0 12.3 4.9 13
%Protein/RNI 72 123.5 104.0-150.5 128.9 34.3
Male 46 125.5 105.0-157.0 131.2 35.2
Female 26 120.0 96.0-143.0 124.7 33.1
(Continues)
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TABLE 2 (Continued)
Variable Number Median IQR Mean SD NSDS mean
Males (age)
19-64 39 125.0 104.0-157.0 129.7 36.0
≥65 6 124.5 122.0-131.0 130.0 19.9
Females (age)
19-64 19 120.0 95.0-148.0 125.1 36.4
≥65 7 122.0 110.0-143.0 123.4 24.1
Protein (g)/day 71 70.0 55.0-85.0 67.5 20.7 74.4
Male 45 75.0 62.0-89.0 75.7 22.0
Female 26 60.5 51.0-70.0 66.6 14.6
Males (age)
19-64 38 76.5 58.0-91.0 75.7 23.7 84.6
≥65 6 73.5 67.0-76.0 71.0 10.0 74.4
Females(age)
19-64 20 58.5 51.0-77.0 67.4 15.8 64.4
≥65 6 60.6 57.0-61.0 58.7 9.9 64.3
Selenium (%RI) 74 56.0 38.0-72.0 55.4 21.5 72
Male 45 56.0 36.0-75.0 56.0 22.2
Female 27 56.0 39.0-60.0 53.7 19.0
Males (age)
19-64 39 56.0 40.0-75.0 55.9 20.6 72
≥65 5 31.0 28.0-86.0 53.6 36.4 68
Females(age)
19-64 19 53.0 38.0-60.0 54.0 21.7 72
≥65 8 57.5 48.5-60.0 53 11.2 70
Zinc (%RI) 74 88.0 70.0-108.0 90.8 27.9 103
Male 45 92.0 81.0-108.0 94.6 25.2
Female 27 72.0 62.0-105.0 83.4 31.3
Males (age)
19-64 39 95.0 80.0-119.0 95.0 26.9 101
≥65 5 90.0 87.0-101.0 92.2 11.5 93
Females(age)
19-64 19 70.0 60.0-105.0 82.7 35.1 106
≥65 8 84.0 70.0-106.5 85.3 21.7 108
Vitamin C (%RNI) 74 185.5 101.0-268.0 190.1 104.7
Male 45 200.0 103.0-267.0 190.8 108.5
Female 27 164.0 100.0-278.0 185.1 97.4
Males (age)
19-64 39 219.0 103.0–267.0 199.7 108.9
≥65 5 108.0 104.0-201.0 149.8 94.8
Females (age)
19-64 19 210.0 100.0-290.0 194.7 103.4
≥65 8 162.0 105.5-223 162.4 83.2
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2.2 | Body composition assessment
This was undertaken using standard techniques.7 Objec-
tive data included Mid Upper Arm Circumference
(MUAC in cm) and nondominant arm grip strength (kg).
A digital dynamometer (model MG4800, Marsden
Weighing Scales, Ltd.) was used for all measurements,
undertaken in a consistent sitting position, specifically
chosen for its lightness, for this patient group, as part of a
longitudinal approach. Data from those patients
reporting joint pain in the hand associated with the AKU
condition were excluded from the analysis, most com-
monly the thumb joint affecting ability to grip the device.
Weight, muscle mass, and % body fat/fat mass
(kg) were assessed using bioimpedance measurements
(Tanita scale model DC-430S MA) from 2013 onwards.
Height was taken, using a wall-mounted stadiometer
(Seca 222) accurate to the nearest 0.1 cm. Weight was
taken in light clothing to the nearest 0.1 kg. Body mass
index (BMI) was calculated as the ratio of weight in kg to
the square of height in meters as defined by WHO12 and
for comparative purposes the Powell-Tuck and Hennessy
equation,13 which estimates BMI using MUAC (referred
to as a BMIPTH) was calculated, given height loss and
spine curvature is common in this condition. MUAC and
grip strength readings were compared to USA National
Health & Nutritional Examination Survey (NHANES)14
by age and sex, due to the lack of UK centiles covering
the entire adult population, as is standard professional
practice. Bioimpedance markers were compared to
national centiles.15,16
The data has been collected and analyzed by the same
dietitian from November 2012 (SJ) with the exception of
three patients whose anthropometric data was under-
taken by an experienced dietetically trained assistant.
2.3 | Habitual food intake
This was assessed using a 7-day diet diary, completed
the week before. In a service standardized format, the
diary includes completion notes, a series of questions
about usual eating habits, portion sizes, cooking
methods and in the case of manufactured goods, named
brands (Supporting Information, Data S1). Data was
coded using standardized techniques and entered into
computerized analysis databases (Microdiet version
3, from 2012 to 2014), and nutritics (using Microdiet
version 8 from 2015 onwards17). If weights were not
given, portion sizes were interpreted using Foods Stan-
dards Agency norms.18
Results were compared to UK Dietary Reference
Values (DRV's) adjusted for age and sex, interpreted by
relative nutritional risk, as a percentage of target for each
nutrient's recommended nutrient intake (RNI) and lower
recommended nutrient intake (LRNI) to denote
TABLE 3 Comparing estimated protein intakes from the 7 days food diary and 24 hours urinary nitrogen (g/kg body weight)
Variable Number Median IQR Mean SD
Food diary 72 1.0 0.8-1.2 1.0 0.3
Male 46 1.0 0.8–1.2 1.0 0.3
Female 26 0.9 0.8-1.1 1.0 0.3
Males (age)
19-64 39 1.0 0.8–1.2 1.0 0.3
≥65 6 1.0 0.9-1.1 1.0 0.2
Females (age)
19-64 19 0.9 0.8-1.3 1.0 0.4
≥65 7 1.0 0.8–1.1 1.0 0.2
Urinary N 56 0.9 0.7-1.0 0.9 0.2
Male 36 0.8 0.7–1.0 0.8 0.2
Female 20 0.9 0.7–1.0 0.9 0.2
Males (age)
19-64 31 0.8 0.7–1.0 0.9 0.2
≥65 4 0.8 0.6-1.0 0.8 0.3
Females (age)
19-64 14 0.9 0.7-1.1 0.9 0.3
≥65 6 0.9 0.7–1.0 0.9 0.2
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deficiency risk. Total protein intake was compared to
COMA9 and SACN19-21 and presented as g/kg body
weight. Overall, nutrient intakes were compared with the
National Diet and Nutrient Survey7 to assess potential
differences against national profiles, for the relevant
years of study.
2.4 | Measurements of nutritional
parameters in blood and urine
This included fasting serum albumin (g/L), total protein
(g/L), hemoglobin (g/L), and the total 25-hydroxy vitamin
D (Table 3). Hemoglobin was measured using DxH
800 Hematology Analyser (Beckman Coulter). Total
25-hydroxy vitamin D was measured using liquid chroma-
tography tandem mass spectrometry. Other parameters
were measured using Cobas analysers (Roche). Total pro-
tein intake expressed as g protein/kg per day was calcu-
lated using a 24-hour urinary urea estimation (taking urea
nitrogen to be 80% of total nitrogen), to support the valid-
ity of the estimated protein intake from the food diary, col-
lected at the same time on day 1 of the assessment visit.
An audit of the diet related questions contained
within the NAC's baseline preadmission questionnaire,
provided additional depth to the nutritional overview
(Table 5).
The AKUSSI was assessed as previously described
employing standard items collected when patients attend
for annual visits to the NAC.22
2.5 | Statistical analysis
Variables are presented with their median, mean, SD,
and interquartile range. Pearson's correlation coefficients
and associated P-values were calculated to assess the lin-
ear relationship between protein intake and severity of
disease as defined by the AKUSSI score6 and the relation-
ship of BMI with BMI calculated using the Powell-Tuck
and Hennessey equation (BMIPTH). All statistical ana-
lyses were performed with Stata version 15.1
(StataCorp. 2017. Stata Statistical Software: Release 15.
College Station, TX: StataCorp LLC).
FIGURE 1 A scatter plot showing the relationship between
observed BMI and BMIPTH values Pearson coefficient
r (73) = .87, P < .001
FIGURE 2 Comparing percentage energy contribution of
macro nutrients between males and female AKU patients
TABLE 4 Significant blood biochemistry—Vitamin D
25-Hydroxy vitamin D (nmol/L) Number Median IQR Mean SD UK mean/% < 25 nmol/L
Male 25 35.0 25.0-61.0 49.4 34.5
Female 16 44.0 29.0-85.0 56.8 38.8
Males (age)
19-64 21 33.0 23.0-51.0 55.0 35.1 42.4/22
≥65 3 89.0 50.0-92.0 77.0 23.4 43.5/21
Females (age)
19-64 11 36.0 14.0-63.0 42.4 30.5 45.3/15
≥65 4 103.5 77.0-126.0 101.5 29.2 47.9/9
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3 | RESULTS
3.1 | Body composition
See Table 1 and Figure 1.
3.2 | Nutritional intake
See Tables 2 and 3, and Figure 2.
3.3 | Blood and urine parameters
See Table 4 and Figures 3 and 4.
3.4 | AKUSSI score—potential impact
of diet
See Figures 5 and 6.
3.5 | Audit of diet related questions
within AKU baseline questionnaire
See Table 5.
3.6 | Interpretation
3.6.1 | Body composition
All patients both male and female have a lower MUAC
than the UK population with an IQR between the 5th
and 25th centile. The mean for males across all ages at
30.2 cm is nearest to the 15th centile and is consistent
across all ages. The mean female mid-point MUAC of
29.6 cm is between the 25th and 50th centile. Bio-
impedance data has not been used for comparative pur-
poses using standard equations to provide a fat free mass
index (FFMI) due to the potential inaccuracies of the
height measure and lack of validity for non-White ethnic
groups or those with chronic disease (Franssen et al.,
2014).15,16,23 The Tanita bioimpedance scale can underre-
port fat free mass particularly in low BMI.24,25
3.6.2 | Grip strength
Male and female grip strength is not normally distributed.
Male and female means (33.1 and 22.0 kg, respectively) are
below 85% functionality, which is considered a poor out-
come predictor postmajor surgery,26 an indicator of
increased postoperative complications, increased length of
hospitalization, higher rehospitalization rate, and decreased
physical status and therefore a marker of poor nutritional
status.27 Only one of the 34 men achieved the expectation of
40 kg. None of the 15 females achieved the expectation of
27.5 kg, but numbers are too small to stratify by age. No sin-
gle individual achieved above average muscle functionality.
3.6.3 | Percentage body fat
Compared to the percentage of body fat within a nationally
representative sample adjusted for ethnicity and age,14 the
male AKU patients have a higher percentage fat. Centiles
derived from bioimpedance measures,15,16 indicates the male
mean is on the 75th centile, with an IQR from the 50th to
over the 95th centile. Numbers are too small to stratify by
age, but suggests a consistent pattern of above average fat
scores until the sixth decade when it falls to average norms
then falls below expectations, suggesting a call on nutritional
reserves at this point. Energy stores are depleted for the two
patients in their 4th to 5th decade. Females consistently
(ii) Urinary HGA
(i) Serum
FIGURE 3 Scatter plots to assess impact of daily protein vs
HGA. A, Serum; B, Urinary HGA
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record lower energy intakes than UKmean, yet show a simi-
lar trend of lower than anticipated BMI and % body fat
between the 4th and 5th decades.
3.6.4 | BMI
Sixty-three percent of the adult UK populations are over-
weight or obese28 yet mean BMI for AKUmen was 26.9 and
women 26.3. National data would predict at least one man
and two women within the morbidly obese range, whereas
this cohort has only one female. Incidence of underweight
is not normally distributed with a higher prevalence than
the 2.3% national expectation, with trends indicating a fall
in body weight during the 4th and 5th decade. BMI calcu-
lated using the Powell-Tuck and Hennessey equation
(Figure 1, BMIPTH) is highly correlated for this group, with
a Pearson correlation coefficient of .86, indicating that
although height loss is universal for this group BMI esti-
mates are reliable, which is reassuring since measuring
height is often painful due to ochronosis of the spine.
3.7 | Nutritional intake
3.7.1 | Macronutrient intakes
Mean protein intake for men aged 19 to 64 years is 75.7 g
compared to 67.4 g for women. Men aged ≥65 consume
71.0 g protein daily and 58.7 g for women, which are less
as a percentage of total energy than the UK average
(Table 2). A majority of the UK population takes more
than 100% RNI, but in AKU 12% take less than the mini-
mum 0.74 g protein/kg,29 with older women most at risk.
The shortfall in protein intake is not fully compensated
for by energy from fat, carbohydrate or alcohol, resulting
in a theoretical energy deficit: 118 kcal/day across all
patients and all ages, 404 kcal/day in men over 65 years
with a relatively small SD and a mean of 112 kcal in
women. Amino acid profiles of 50 of these AKU patients
recorded mean phenylalanine, aspartic acid and arginine
(i) %RNI
(ii) Stratified by age
FIGURE 5 Scatter plots to consider protein intake vs AKUSSI
score. A, %RNI; B, Stratified by age
(ii) Urinary HGA
(i) Serum
FIGURE 4 Scatter plots to assess the impact of Protein %RNI
vs HGA. A, Serum; B, Urinary HGA
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(i) Selenium(mg)
(ii) Zinc(mg)
(iii) Vitamin C (mg)
(iv) High dose Vitamin C vs AKUSSI score
FIGURE 6 Scatter plots to consider intake of anti-inflammatories vs AKUSSI score. A, Selenium (mg); B, Zinc (mg); C, Vitamin C
(mg); D, High dose vitamin C vs AKUSSI score
TABLE 5 Audit of diet related questions within AKU baseline questionnaire
N = 74 Number Number
Nos. reporting prior
dietary intervention
35 High dose vitamin C 25 6 taking at visit 1
Received dietary advice
unrelated to AKU
16 (11 for weight
loss)
Glucosamine users 4 2 taking at visit 1
Self-selected food
manipulation
15 (14 vegetarian
and 1 vegan)
Daily portions of fruit
and vegetable
Male
average 3
Female average 3.6
On a prescribed “diet”
for AKU
17 (15 for low protein/
2 for weight loss)
Over the counter
nutritional supplement
users
29 3 fish oils
Prescribed diet advised
by a dietitian
7 Prescribed nutritional
supplement
11 7 vitamin D3 (3 with
calcium), 2
vitamin B12, and
2 vitamin C
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levels outside the normal reference range at initial
assessment.30
There is a highly statistically significant association
between the estimated protein intake from the food diary
record (Table 3) and the 24 hours urinary nitrogen esti-
mation (r (53) = .52, P < .001) suggesting the food diaries
fairly reflect protein intake, which is irrespective of gen-
der (r (34) = .67, P = .002 and r (18) = .48, P = .003
males/females, respectively).
The mean intake of protein expressed in g/kg is similar
to the 1.0 g protein/kg reported in other AKU patients.3
Although not statistically significant, the estimated protein
intake using urinary nitrogen trend was consistently lower
for males and females across all age groups.
Total energy intake is consistently lower across all
patients than reported national data, particularly among
men. Older women take closer to the recommended 50%
of total energy from carbohydrate than others, but with
total fiber below average. This is most likely derived from
nonextrinsic sugars, not untypical in older age choosing
easy reach snack foods such as biscuits and cakes
(Figure 2).
Overall alcohol intake is low in this group, with 68%
abstaining from alcohol altogether compared to 15% of
men and 21% of women nationally.31 The average per-
centage energy from alcohol is 3% for men and 0.4% for
women, compared to 4.4% across all adults in the United
Kingdom.
3.7.2 | Micronutrient
Intakes mirror those for the UK diet as a whole, with
fewer portions of fruit and vegetables and total fiber.
Those recording an LRNI are within normal population
expectations. Wide standard deviations and small numbers
prevent accurate interpretation by age. As a subgroup,
there are 13 vegetarians and 1 vegan (all of Asian origin).
The 11 men average 10.3 mg iron/day, just within the
10 to 15 mg daily range: the 3 women (averaging 10.7 mg)
are well within national expectation (8-13 mg/day).
3.8 | Blood and urine measurements
3.8.1 | Serum albumin (g/L) and
hemoglobin
Serum albumin (g/L) and hemoglobin concentration
records are within national expectations and normally
distributed for age and sex (Table 4). Prealbumin, as an
inflammatory marker, is a valid predictor of nutritional
risk32 and protein catabolism,33 not currently measured.
3.8.2 | Serum total 25-hydroxy vitamin D
(normal values above 50 nmol/L D2 + D3)
A mean of 49.4 nM for males, with no recorded level
below 25 nM, compares to national levels. Females'
record a mean of 56.8 nM compared with the national
mean of 45 nmol/L, while none recorded less than
25 nM; the national expectation would be 15%—
reflecting the frequency of prescribed supplementation of
the 20% of AKU patients in this cohort of Asian origin.34
3.8.3 | Homogentisic acid
Figure 3 considers the potential impact of dietary protein
intake on serum and urinary HGA as a %RNI and as g/kg
actual weight. There appears to be a possible inverse qua-
dratic relationship between protein intake and serum
HGA. Patients with a protein %RNI > 150 or protein
intake above 1 g/kg may experience lower serum HGA
levels. All serum HGA < 40 for %RNI > 150. No differ-
ences were observed between serum HGA, when intakes
of selenium, zinc or vitamin C were considered.
3.9 | AKUSSI score
Mean AKUSSI and %RNI for protein by age (Table 6), shows
an increasing score, but relatively stable protein intake.
AKUSSI correlations have been undertaken to investigate
the potential impact of protein expressed as g/kg and %RNI
and stratified by age (Figure 5) and the potential impact of
anti-inflammatory nutrients (vitamin C, selenium, and
zinc), alongside the potential impact of high dose vitamin C,
given their historical potential significance in the literature
(Figure 6). All demonstrate no association.
3.10 | Audit overview
The preadmission questionnaire data (Table 5) suggests
many AKU patients have tried to manipulate their diet at
some point in their lives. Limiting protein and supple-
ments of vitamin C, glucosamine and/or chondroitin are
the most frequent dietary approaches reported. Fifty
TABLE 6 Comparison of mean AKUSSI and %RNI for protein
by age
Age Mean AKUSSI (SD) Mean %RNI protein (SD)
<40 30.5 (17.5) 146.3 (42.7)
40 ≤ 65 93.8 (28.7) 125.8 (36.6)
≥65 113.4 (23.2) 130.2 (21.6)
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percent of all patients reported some level of dietary pro-
tein manipulation over their lives, 42% of which recorded
a low protein diet, yet less than half had been referred
to a dietitian for dietary guidance. Twenty percent of
patients report being “on a diet for AKU” at visit 1.
4 | DISCUSSION
This is the most comprehensive study of the nutritional
status of people with AKU reported in the literature. Evi-
dence collected, using a variety of valid nutritional surveil-
lance techniques, provides the opportunity to consider the
overall nutritional status, which is hitherto unreported in
this genetic condition. Those with AKU have frequently
been advised to manipulate their diets at some point in
their lives (Table 5), based on the limited anecdotal evi-
dence from the literature, which includes limiting total
protein intake and taking prophylactic doses of vitamin
C. The lack of correlation between the AKUSSI score and
intakes of protein, expressed as either %RNI or as g/kg or
any anti-inflammatory nutrients, when stratified by age,
provides further evidence of the inappropriateness of die-
tary manipulation as treatment for this condition.1,35
AKU patients have lower muscle mass and higher %
body fat as evidenced through bioimpedance, signifi-
cantly lower grip strength, MUAC and BMI across all age
groups. This suggests a chronically protein-depleted diet,
best described as under-nourished36 or more accurately
“diet related malnutrition without inflammation” termed
DRM (ESPEN, 201737).
Previous attempts to control weight to minimize the
impact of ochronosis on joints and cartilage could have
had an impact in addition. Reduced muscle stores and
muscle functionality, results in a reduced basal metabolic
rate. This in turn makes weight gain more likely, seen
here as a higher % body fat. With less metabolically active
tissue and reduced mobility associated with the joint and
cartilage destruction, there is a risk of obesity over time,
increasing the burden of disease.
The nutritional analyses indicates a lower than average
protein intake than the UK norm, but it cannot be consid-
ered “low” in a therapeutic sense and the food diary itself
reflects only a moment in time as opposed to a life-time
dietary behavior. Although the average estimated protein
intake of 1 g/kg body weight is within the recommended
range, two of the seven patients with recorded protein
intakes below the minimum 0.74 g/kg, were vegetarian,
suggesting an additional over-arching risk. This consis-
tently near minimum protein intake provides little scope
for episodes of increased need over the life course.38
The possibility of the condition itself having an
impact on muscle development must also be considered,
since phenylalanine and tyrosine are proteinogenic
amino acids, with tyrosine a precursor of melanin, epi-
nephrine and thyroid hormones.39
Patients with AKU frequently require joint replace-
ments by their fourth and fifth decade. Some have under-
gone often multiple joint replacements prior to visiting
the NAC. These periods of high protein/energy require-
ments, create pinch points of higher metabolic demand
impacting on muscle and fat reserves and consequently
BMI, potentially explaining why observed trends in obe-
sity regress during the 5th and 6th decade, when joint
replacements are routine treatment strategies. This in
turn represents an additional risk for patients with AKU,
for extended bed stay and adverse outcome associated
with malnutrition.40 The lower total energy intake and
reduced mobility associated with the condition itself risks
muscle atrophy, as a result of increased breakdown and
decreased synthesis.41
HGA-lowering therapy, using nitisinone, is now a pos-
sibility in AKU treatment.22 Nitisinone has been used as
the standard of care in hereditary tyrosinaemia 1 for more
than 20 years with remarkable success, transforming the
care of this previously fatal tyrosine pathway disorder.
Nitisinone inhibits p-hydroxyphenylpyruvate dioxygenase,
thereby decreasing distal metabolites including HGA.
While this HGA-lowering effect is beneficial in AKU, by
introducing a proximal metabolic block, nitisinone results
in tyrosinaemia.42 Postnitisinone tyrosinaemia has been
associated with unwanted corneal keratopathy (with a
potential to cause blindness), cutaneous rashes, and cog-
nition effects, which can be mitigated by a lower dietary
tyrosine intake.23
4.1 | Implications for future clinical
practice
Manipulating protein and energy intake as a conse-
quence of treating AKU presents a challenging therapeu-
tic demand. Dietary strategies need to support adequate
nutritional intake, limit protein, yet maintain already
depleted muscle mass, even though exercise tolerance
may be compromised, limit further fat accumulation and
maintain nutritional status during potentially repeated
episodes of increased metabolic demand, while
maintaining a safe serum tyrosine.
4.2 | Therapeutic considerations
1. Bioimpedance measures (BIA) augment standard
anthropometry to monitor body composition trends,
particularly muscle and fat mass, since joint pain in
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AKU affects use of dynamometers and scoliosis affects
skin fold points.
2. Estimate BMI using a MUAC,13 as a simple, noninva-
sive measure, since ochronosis of the spine makes
measuring height painful.
3. Strategies to maintain integrity of lean body mass,
such as resistance exercise to help minimize the risk
of muscle atrophy and sarcopenia associated with
older age.43
4. Include serum prealbumin measurement as part of
routine biomedical analysis.
4.3 | Areas of future service
development
1. Establish a robust pre- or peri-operative feeding
regime prior to joint replacement surgery to ensure
AKU patients are not included in the 60% elderly
patients who are protein-energy undernourished on
hospital admission or develop serious nutritional defi-
cits delaying discharge.
2. A strategic cascade of this body composition data
across the AKU community, particularly parents and
careers of children with AKU, to raise awareness of
the risk of inadequate protein/energy intake during
the growing years.
4.4 | Limitations of this study
1. Using bioimpedance to measure body composition is
less accurate than gold standard DEXA scan for body
composition analysis,12,13 as it may overestimate fat
free mass compared with DXA.25,44
2. The digital grip strength dynamometer requires vali-
dation against the gold standard Jamar hand grip
dynometer (Patterson Medical).
3. Using NHANES study reference data to interpret per-
centage body fat as their multiethnic population dif-
fers from this group.45,46
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